Found 7 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Integrin alpha-V/beta-6
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Antagonist activity at human integrin alphaVbeta6 expressed in human K562 cells assessed as reduction in cell adhesion to GST-LAP after 30 mins by BC... |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Integrin alpha-V/beta-8
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Antagonist activity at human integrin alphaVbeta8 expressed in human K562 cells assessed as reduction in cell adhesion to GST-LAP after 30 mins by BC... |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Integrin alpha-V/beta-5
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Antagonist activity at human integrin alphaVbeta5 expressed in human K562 cells assessed as reduction in cell adhesion to vitronectin after 30 mins b... |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Integrin alpha-V/beta-3
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Antagonist activity at human integrin alphaVbeta3 expressed in human K562 cells assessed as reduction in cell adhesion to GST-LAP after 30 mins by BC... |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Integrin alpha-V/beta-1
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Antagonist activity at human integrin alphaVbeta1 expressed in human A549 cells assessed as reduction in cell adhesion to GST-LAP after 30 mins by BC... |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.51E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in HEK293 cells by Q-patch assay |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50464107
(CHEMBL4240155)Show SMILES Cc1cc([nH]n1)-c1cccc(c1)[C@@H](CN1CC[C@@H](CCc2ccc3CCCNc3n2)C1)CC(O)=O |r| Show InChI InChI=1S/C28H35N5O2/c1-19-14-26(32-31-19)23-5-2-4-22(15-23)24(16-27(34)35)18-33-13-11-20(17-33)7-9-25-10-8-21-6-3-12-29-28(21)30-25/h2,4-5,8,10,14-15,20,24H,3,6-7,9,11-13,16-18H2,1H3,(H,29,30)(H,31,32)(H,34,35)/t20-,24-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | <5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Strathclyde
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in HEK293 cells by Barracuda automated patch clamp assay |
J Med Chem 61: 8417-8443 (2018)
Article DOI: 10.1021/acs.jmedchem.8b00959 BindingDB Entry DOI: 10.7270/Q24T6N25 |
More data for this Ligand-Target Pair | |